User Tools

Site Tools


documentation:oncology:meeting_notes_2019_jun-18

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
Last revision Both sides next revision
documentation:oncology:meeting_notes_2019_jun-18 [2019/06/20 11:09]
mgurley
documentation:oncology:meeting_notes_2019_jun-18 [2019/06/20 11:15]
mgurley
Line 3: Line 3:
 **Topics** **Topics**
  
-* The group reviewed the following presentation:​ 
-{{:​documentation:​oncology:​ohdsi_oncology_meeting_06_18_2019.pdf| Presentation}} 
  
-* The group discussed SQL showing how to map ICDO Site/​Histology combinations to pre-coordinated Condition concepts. 
  
-* The group discussed SQL showing how to find all Site/​Histology combinations containing a particular ICDO site or histology.+  ​* The group reviewed the following presentation:​ {{:​documentation:​oncology:​ohdsi_oncology_meeting_06_18_2019.pdf| Presentation}}
  
-It was announced that ICDO is currently already implemented within Athena and folks should try mapping their ICDO data.+  ​The group discussed the following questions:
  
-The group discussed the plan to adopt NAACCR as OMOPS'​s standard vocabulary ​of cancer ​diagnosis modifiers and the plant to transition NAACCR from a standard ​vocabulary ​to source vocabulary by mapping NAACCR to the Nebraska Lexicon.+  ​Should representation ​of cancer ​staging within ​the OMOP vocabulary ​preserve ​the differences in possible values for cancer staging across anatomic site?  Or should the list of possible values be collapsed across anatomic sites? 
 +    * Group Consensus Answer:the list of possible values be collapsed across anatomic sites 
  
-Concern was expressed regarding the timeline for when the Nebraska Lexicon would be completed. +  ​Should ​representation of cancer ​staging ​within the OMOP vocabulary ​include system (AJCC vsUICC vs others) ​and version? Or should the list of possible values be collapsed across systems and versions? 
- +    Group Consensus Answer: ​The list of possible values be collapsed across systems ​and versions.
-* There was consensus in the group that the OMOP community needs to standardize the representation of cancer ​ ​diagnosis modifiers. ​ Some members of the group might take a swipe at recommending cancer diagnosis modifiers ahead of the Nebraska Lexicon completion date. +
- +
-* It was announced that the Hemonc.org drug regimen ontology has been released ​within ​Athena. +
- +
-* The group discussed ​the current state of the Hemonc.org ​vocabulary. ​ ​Regimens ​and regimen components mapped to RxNorm ingredients. ​ Plus a better drug oncology classification system. +
- +
-* The group asked about the future possibility ​of including regimen dosing, cycles ​and indications. ​ Dmytry informed the group that these items would be part of future releases.+
  
documentation/oncology/meeting_notes_2019_jun-18.txt · Last modified: 2019/06/20 11:16 by mgurley